Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Deloitte
Baxter
QuintilesIMS
Mallinckrodt
McKinsey
UBS
Healthtrust
Chinese Patent Office
Merck

Generated: January 16, 2018

DrugPatentWatch Database Preview

Ziprasidone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ziprasidone hydrochloride and what is the scope of ziprasidone hydrochloride freedom to operate?

Ziprasidone hydrochloride
is the generic ingredient in two branded drugs marketed by Pfizer, Apotex Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Inc, Lupin Pharms, Macleods Pharms Ltd, Mylan Pharms Inc, Sandoz Inc, Wockhardt Ltd, Zydus Pharms Usa Inc, and Pfizer Inc, and is included in eleven NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ziprasidone hydrochloride has one hundred and thirty-two patent family members in fifty-three countries.

There are twenty-one drug master file entries for ziprasidone hydrochloride. Thirty-five suppliers are listed for this compound.
Summary for ziprasidone hydrochloride
Pharmacology for ziprasidone hydrochloride

US Patents and Regulatory Information for ziprasidone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-004 Feb 5, 2001 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Aurobindo Pharma Ltd ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 204117-004 Dec 27, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077561-001 Mar 2, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt Ltd ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 090348-002 Sep 5, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077562-001 Jun 1, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Inc ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077565-004 Mar 2, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-002 Feb 5, 2001 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wockhardt Ltd ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 090348-003 Sep 5, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077562-002 Jun 1, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc ZIPRASIDONE HYDROCHLORIDE ziprasidone hydrochloride CAPSULE;ORAL 077561-003 Mar 2, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ziprasidone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-002 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-001 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-004 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-004 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-001 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-002 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer Inc GEODON ziprasidone hydrochloride SUSPENSION;ORAL 021483-001 Mar 29, 2006 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-003 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer Inc GEODON ziprasidone hydrochloride SUSPENSION;ORAL 021483-001 Mar 29, 2006 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-003 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for ziprasidone hydrochloride

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Argus Health
Medtronic
US Department of Justice
Queensland Health
Fish and Richardson
AstraZeneca
Boehringer Ingelheim
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot